17,261 trials
Eosinophilic Esophagitis
Primary: Absolute Change From Baseline in Straumann Dysphagia Instrument (SDI) Patient Reported Outcome (PRO) Total Score at Week 10 — -1.3; -3.0 Score on a Scale — p=0.0304
Chronic Lymphocytic Leukemia
Primary: Rate of Complete Remission/Complete Remission With Incomplete Recovery of the Bone Marrow (CR/CRi), as Assessed by Investigator Using Modified International Workshop on…
Head and Neck Squamous Cell Carcinoma
Primary: Change in Immune Response After Tadalafil Administration
Classic Hodgkin Lymphoma · Lugano Classification Stage III Hodgkin Lymphoma AJCC v8 · Lugano Classification Stage IV Hodgkin Lymphoma AJCC v8
Primary: Event-free Survival (EFS) Rate — 17; 20 Participants
Devic's Disease
Primary: Survival — 13; 12; 12; 11 Participants
Recurrent Epithelial Ovarian Cancer · Recurrent Fallopian Tube Cancer · Recurrent Primary Peritoneal Cancer
Primary: Overall Response Rate (ORR) — 4 participants
Obsessive-Compulsive Disorder
Primary: Change in Yale-Brown Obsessive Compulsive Scale — 24.0; 14.2; 2.5; 11.2 score on a scale
Colorectal Adenocarcinoma · RAS Wild Type · Stage IV Colorectal Cancer AJCC v7
Primary: Progression-Free Survival (PFS) — 9.7; 5.5 months — p=0.7609
Systemic Lupus Erythematosus
Primary: Survival — 28; 2; 28; 0 Participants
Rheumatoid Arthritis
Primary: Change From Baseline in the Simplified Disease Activity Index (SDAI) at Week 12 — -13.87; -21.71; -22.83; -24.77 units on a scale — p=0.0050
Accidental Falls · Fall Due to Loss of Equilibrium · High Risk of Falls Due to Mobility Limitation
Primary: Hip Sway Change From Baseline to 6 Months — 3.65; 3.75; 2.15; 3.89 degree^2 — p=0.040
Diabetes · PAD · Lower Extremity Edema
Primary: Change in Balance From Baseline to 4 Weeks — 0.94; 0.76 cm
Cardiovascular Diseases
Primary: Forearm Blood Flow Responses to Hypoxia After Administration of Intervention — 6.3; 6.2; 2.1; 8.4 mL/min — p=0.97
Genitourinary Cancer · Kidney Cancer
Primary: Rate of Toxicity — 15; 8; 5; 3 Participants
Pigmented Villonodular Synovitis · PVNS · Giant Cell Tumor of the Tendon Sheath
Primary: Change in Pigmented Villonodular Synovitis (PVNS) Tumor Size — -4222.8; -668.5; -9998.4; -38002.1 mm3